Meng X - Search Results

1

Design, Synthesis, and Biological Evaluation of Novel Trifluoromethylated Dipeptide Mimetics of Matijin-Su as Potent Anti-HBV Agents.

Shao X, Kuang A, Xu G, Yu G, Xu B, Kong X, Meng X, Zeng X. Shao X, et al. Among authors: meng x. Chem Biodivers. 2024 Dec 23:e202402061. doi: 10.1002/cbdv.202402061. Online ahead of print. Chem Biodivers. 2024. PMID: 39714596

2

Discovery of novel 2-(trifluoromethyl)quinolin-4-amine derivatives as potent antitumor agents with microtubule polymerization inhibitory activity.

Liu K, Mo M, Yu G, Yu J, Song SM, Cheng S, Li HM, Meng XL, Zeng XP, Xu GC, Luo H, Xu BX. Liu K, et al. Bioorg Chem. 2023 Oct;139:106727. doi: 10.1016/j.bioorg.2023.106727. Epub 2023 Jul 8. Bioorg Chem. 2023. PMID: 37451147

3

Design, synthesis and bioevaluation of novel trifluoromethylquinoline derivatives as tubulin polymerization inhibitors.

Zhang S, Mo M, Lv M, Xia W, Liu K, Yu G, Yu J, Xu G, Zeng X, Cheng S, Xu B, Luo H, Meng X. Zhang S, et al. Among authors: meng x. Future Med Chem. 2023 Nov;15(21):1967-1986. doi: 10.4155/fmc-2023-0151. Epub 2023 Nov 8. Future Med Chem. 2023. PMID: 37937524

4

Design, synthesis and bioevaluation of novel prenylated chalcones derivatives as potential antitumor agents.

Yu J, Wang X, Cheng S, Zeng X, Wan X, Wei S, Xu B, Luo H, Meng X. Yu J, et al. Among authors: meng x. Eur J Pharm Sci. 2024 Jan 1;192:106660. doi: 10.1016/j.ejps.2023.106660. Epub 2023 Dec 3. Eur J Pharm Sci. 2024. PMID: 38052256 Free article.

5

Design, synthesis and antitumor activity of 2-substituted quinazoline-4-amine derivatives.

Wang M, Yu J, Huang X, Yu G, Liang Q, Cheng S, Meng X, Xu G, Li H, Luo H, Xu B. Wang M, et al. Among authors: meng x. Bioorg Med Chem. 2024 Mar 15;102:117660. doi: 10.1016/j.bmc.2024.117660. Epub 2024 Mar 1. Bioorg Med Chem. 2024. PMID: 38442524

6

Design and synthesis of N-aryl-2-trifluoromethyl-quinazoline-4-amine derivatives as potential Werner-dependent antiproliferative agents.

Li H, Yu J, Yu G, Cheng S, Wu H, Wei J, You C, Liu K, Wang M, Meng X, Xu G, Luo H, Xu B. Li H, et al. Among authors: meng x. Mol Divers. 2024 May 13. doi: 10.1007/s11030-024-10844-6. Online ahead of print. Mol Divers. 2024. PMID: 38739229

7

Discovery of novel 4-trifluoromethyl-2-anilinoquinoline derivatives as potential anti-cancer agents targeting SGK1.

Xu G, Li L, Lv M, Li C, Yu J, Zeng X, Meng X, Yu G, Liu K, Cheng S, Luo H, Xu B. Xu G, et al. Among authors: meng x. Mol Divers. 2024 Aug 9. doi: 10.1007/s11030-024-10951-4. Online ahead of print. Mol Divers. 2024. PMID: 39117890

8

Discovery of novel N-aryl-2-trifluoromethyl-quinazoline-4-amine derivatives as the inhibitors of tubulin polymerization in leukemia cells.

Wu H, Wang LS, Li P, Yu J, Cheng S, Yu G, Ahmad M, Meng XL, Luo H, Xu BX. Wu H, et al. Eur J Med Chem. 2023 Aug 5;256:115470. doi: 10.1016/j.ejmech.2023.115470. Epub 2023 May 8. Eur J Med Chem. 2023. PMID: 37201429

9

Trifluoromethyl quinoline derivative targets inhibiting HDAC1 for promoting the acetylation of histone in cervical cancer cells.

Zhang T, Zhou C, Lv M, Yu J, Cheng S, Cui X, Wan X, Ahmad M, Xu B, Qin J, Meng X, Luo H. Zhang T, et al. Among authors: meng x. Eur J Pharm Sci. 2024 Mar 1;194:106706. doi: 10.1016/j.ejps.2024.106706. Epub 2024 Jan 19. Eur J Pharm Sci. 2024. PMID: 38244809 Free article.

10

Lewis acid mediated cyclization: synthesis of 2 spirocyclohexylindolines.

Kong XK, Xiong ZM, Zhi X, Meng XL, Zhao JF, Chen W, Zhang H. Kong XK, et al. Among authors: meng xl. Org Biomol Chem. 2021 May 12;19(18):4043-4047. doi: 10.1039/d1ob00293g. Org Biomol Chem. 2021. PMID: 33885129

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,241 results

Search Page

Filters